ImmunologybioRxiv
Versican Proteolysis Predicts Immune Effector Infiltration And Post-Transplant Survival In Myeloma
B. Dhakal, A. Pagenkopf, M. U. Mushtaq…·F. Asimakopoulos
This study shows that VCAN proteolysis predicts CD8+ T cell infiltration and poor survival after myeloma transplantation, suggesting it as a biomarker for relapse risk.
DOI 10.1080/10428194.2019.1585836